Showing 2241-2250 of 5957 results for "".
- Locus Biosciences Announces Collaboration with Viatris to Develop Antibacterial Therapies for Ophthalmic Infectionshttps://modernod.com/news/locus-biosciences-announces-collaboration-with-viatris-to-develop-antibacterial-therapies-for-ophthalmic-infections/2484292/Locus Biosciences announced a research collaboration agreement with Viatris to develop novel engineered bacteriophage therapies targeting ophthalmic bacterial infections. While financial terms of the deal were not disc
- NEJM Publishes Study Demonstrating Vision Restoration with Brain-Computer Interface Retinal Implanthttps://modernod.com/news/nejm-publishes-study-demonstrating-vision-restoration-with-brain-computer-interface-retinal-implant/2484211/The New England Journal of Medicine (NEJM) published results from a clinical trial demonstrating that Science Corporation’s PRIMA brain-computer interface (BCI) retinal implant can restore functional
- Ophthalmic World Leaders (OWL) Announces 2025 Leadership Award Honoreeshttps://modernod.com/news/ophthalmic-world-leaders-owl-announces-2025-leadership-award-honorees/2484206/Ophthalmic World Leaders (OWL) announced its 2025 Leadership Award honorees, leaders who are shaping the future of eyecare through innovation, inclusion, and impact. The 2025 OWL Award recipients:
- Sight Sciences Announces Fee Schedule Establishment for TearCare Dry Eye Procedurehttps://modernod.com/news/sight-sciences-announces-fee-schedule-establishment-for-tearcare-dry-eye-procedure/2484193/Sight Sciences announced that two Medicare Administrative Contractors (MACs), Novitas Solutions and First Coast Service Options (FCSO), each established jurisdiction-wide pricing for CPT code 0563T (evacuation of meibomian glands, using heat delivered through wearable, open-eye eye
- FDA Selects Dompé for National Priority Voucher Program to Accelerate Development of Novel Intranasal Therapyhttps://modernod.com/news/fda-selects-dompe-for-national-priority-voucher-program-to-accelerate-development-of-novel-intranasal-therapy/2484190/Dompé announced its selection by the FDA to participate in the Commissioner’s National Priority Voucher (CNPV) program. Through this designation, Dompé has been awarded a voucher granting a signific
- Topcon Healthcare Signs Definitive Agreement to Acquire Toku Inc.https://modernod.com/news/topcon-healthcare-signs-definitive-agreement-to-acquire-toku-inc/2484189/Topcon Healthcare announced it has signed a definitive agreement to acquire Toku, Inc., a San Diego-based artificial intelligence (AI) health technology company. Financial terms of the deal were not disclosed.
- OcuSciences Secures CE Mark for OcuMet Beacon, Expands European Deploymenthttps://modernod.com/news/ocusciences-secures-eu-ce-clearance-for-ocumet-beacon-expands-european-deployment/2484181/OcuSciences has received CE Mark clearance for its OcuMet Beacon, a diagnostic instrument designed to enhance clinicians’ ability to assess eye health and detect retinal disorders. The CE mark signifies that the OcuMet Beacon meets the health, safet
- CORE Highlights Emerging Focus on Pre-Myopia in Latest Contact Lens Updatehttps://modernod.com/news/core-highlights-emerging-focus-on-pre-myopia-in-latest-contact-lens-update/2484173/The Centre for Ocular Research & Education (CORE) has released the newest edition of Contact Lens Update, spotlighting the growing clinical and scientific interest in pre-myopia. This evolving area of study is reshaping how clinicians assess risk, intervene ear
- Heidelberg and NetraMind Collaborate to Deliver AI-Powered Choroid Analysis on AppWay Marketplacehttps://modernod.com/news/heidelberg-and-netramind-collaborate-to-deliver-ai-powered-choroid-analysis-on-appway-marketplace/2484166/Heidelberg Engineering announced a new collaboration with NetraMind Innovations, an AI-driven image analysis software company founded by retinal specialists and machine learning engineers. Their new application, NMI-ChoroidAI,* is now available via the Heidelb
- Lovell and DefEYE Partner to Expand Access to Biovance Ocular Biologics Across Federal Healthcare Systemshttps://modernod.com/news/lovell-government-services-and-defeye-partner-to-expand-access-to-biovance-ocular-biologics-across-federal-healthcare-systems/2484164/Lovell Government Services and DefEYE, the provider of Biovance decellularized basement membranes for ocular use, announced a partnership to serve federal healthcare systems, including the Veterans Health Administration, the Department of Defense Military